GlaxoSmithKline R&D Bangalore India
Research
Date range: 1 December 2022 - 30 November 2023
No articles found. GlaxoSmithKline R&D Bangalore did not contribute to any primary research papers from Nature Index journals in the current 12 month window.Relationships
GlaxoSmithKline plc. (GSK)
-
↳ GlaxoSmithKline R&D Bangalore
- Cellzome GmbH
- GSK Neural Pathways Discovery Performance Unit, Singapore
- GSK Vaccines Institute for Global Health Srl
- GlaxoSmithKline (GSK) Jurong
- GlaxoSmithKline AG, Switzerland
- GlaxoSmithKline Australia Pty. Ltd.
- GlaxoSmithKline Belgium
- GlaxoSmithKline France
- GlaxoSmithKline GmbH & Co. KG
- GlaxoSmithKline Ireland
- GlaxoSmithKline Oy
- GlaxoSmithKline Panamá
- GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline R&D China
- GlaxoSmithKline R&D Verona
- GlaxoSmithKline Spain
- GlaxoSmithKline Sweden
- GlaxoSmithKline UAE
- GlaxoSmithKline USA
- GlaxoSmithKline Vaccines (GSK Vaccines)
- GlaxoSmithKline Vaccines Singapore
- Glycovaxyn AG
- Human Genome Sciences, Inc.
- Novartis Vaccines and Diagnostics
- Novartis Vaccines and Diagnostics GmbH
- Novartis Vaccines and Diagnostics, Inc.
- Novartis Vaccines and Diagnostics, Inc. - Cambridge
- Okairos AG
- Sirtris Pharmaceuticals, Inc.
- TESARO, Inc.